No Data
No Data
Annovis Bio | 10-Q: Quarterly report
Express News | Annovis Reports Completion Of Data Cleaning For Phase III Study Of Buntanetap In Patients With Early Parkinson's Disease; Topline Efficacy Data Is Expected In June
Express News | Annovis Bio Inc - Topline Efficacy Data Is Expected in June
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's Disease
Thu, 09 May 2024MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neur
Annovis Bio Issues Key Update on Corporate Progress
Express News | Annovis Bio - Believe FDA Will Accept Buntanetap for Symptomatic Relief,Will Allow to Continue Next Pivotal Phase III Study for Disease-Modification
No Data
Mod Tan : Im in GL to all